Newsroom

Press Release

NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance

NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore

NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter

NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida

NeoGenomics Schedules its Second Quarter Earnings Release for July 30, 2019

NeoGenomics Announces New $250 Million Credit Agreement

NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference

NeoGenomics and QIAGEN Collaborate to Offer Companion Diagnostic Test for HR+/HER2 - Advanced Breast Cancer Patients to Detect a PIK3CA Mutation

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients